Literature DB >> 27651416

NOD2-RIP2-Mediated Signaling Helps Shape Adaptive Immunity in Visceral Leishmaniasis.

Manuela S L Nascimento1,2, Marcela D Ferreira1, Gustavo F S Quirino1, Sandra R Maruyama1, Jayendra K Krishnaswamy3, Dong Liu4,5, Jonilson Berlink1, Denise M Fonseca1, Dario S Zamboni1, Vanessa Carregaro1, Roque P Almeida6, Thiago M Cunha1, Stephanie S Eisenbarth4,5, João S Silva1.   

Abstract

Interferon γ (IFN-γ) and interleukin 17A (IL-17A)-producing cells are described to be related to the protection against Leishmania infantum infection. How the immune system coordinates the balance between T-helper type 1 (Th1) and 17 (Th17) responses during visceral leishmaniasis (VL) is still unknown. Here, we combined transcriptional profiling, using RNA sequencing analysis of human samples, with an experimental model to show that Th17-related genes are suppressed and that Th1 signature genes are induced during human VL. The high amount of Th1 cells in VL was dependent on the NOD2-RIP2 signaling in dendritic cells, which was crucial for interleukin 12 production through the phosphorylation of MAPK. On the other hand, this pathway inhibits Th17 cells by limiting interleukin 23 production. As a consequence, Nod2-/- and Rip2-/- mice showed defects in Th1 responses and higher parasite loads as compared to WT mice. Together, the data demonstrate that the NOD2-RIP2 pathway is activated in murine and human VL and plays a role in shaping adaptive immunity toward a Th1 profile.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Leishmania infatum; NOD2; RIP2; adaptive immunity; dendritic cells; visceral leishmaniasis

Mesh:

Substances:

Year:  2016        PMID: 27651416     DOI: 10.1093/infdis/jiw446

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Authors:  Leo A B Joosten; Fátima Ribeiro-Dias; Rodrigo Saar Gomes; Muriel Vilela Teodoro Silva; Jéssica Cristina Dos Santos; Christine van Linge; Juliana Machado Reis; Mauro Martins Teixeira; Sebastião Alves Pinto; Miriam Leandro Dorta; Xiyuan Bai; Edward D Chan; Charles A Dinarello; Milton Adriano Pelli Oliveira
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

2.  The NOD2 receptor is crucial for immune responses towards New World Leishmania species.

Authors:  Jéssica Cristina Dos Santos; Michelle S M A Damen; Marije Oosting; Dirk J de Jong; Bas Heinhuis; Rodrigo Saar Gomes; Carla Santos Araújo; Mihai G Netea; Fátima Ribeiro-Dias; Leo A B Joosten
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

3.  Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection.

Authors:  Sandra Regina Maruyama; Carlos Alessandro Fuzo; Antonio Edson R Oliveira; Luana Aparecida Rogerio; Nayore Tamie Takamiya; Gabriela Pessenda; Enaldo Vieira de Melo; Angela Maria da Silva; Amélia Ribeiro Jesus; Vanessa Carregaro; Helder I Nakaya; Roque Pacheco Almeida; João Santana da Silva
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

4.  Lipophosphoglycan From Dermotropic New World Leishmania Upregulates Interleukin-32 and Proinflammatory Cytokines Through TLR4 and NOD2 Receptors.

Authors:  Murilo Barros Silveira; Rodrigo Saar Gomes; Marina Tiemi Shio; Jeronimo Nunes Rugani; Larissa Ferreira Paranaiba; Rodrigo Pedro Soares; Fátima Ribeiro-Dias
Journal:  Front Cell Infect Microbiol       Date:  2022-03-23       Impact factor: 5.293

5.  RIP2 Is a Critical Regulator for NLRs Signaling and MHC Antigen Presentation but Not for MAPK and PI3K/Akt Pathways.

Authors:  Xiao Man Wu; Wen Qin Chen; Yi Wei Hu; Lu Cao; Pin Nie; Ming Xian Chang
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

6.  Non-Leishmania Parasite in Fatal Visceral Leishmaniasis-Like Disease, Brazil.

Authors:  Sandra R Maruyama; Alynne K M de Santana; Nayore T Takamiya; Talita Y Takahashi; Luana A Rogerio; Caio A B Oliveira; Cristiane M Milanezi; Viviane A Trombela; Angela K Cruz; Amélia R Jesus; Aline S Barreto; Angela M da Silva; Roque P Almeida; José M Ribeiro; João S Silva
Journal:  Emerg Infect Dis       Date:  2019-11       Impact factor: 6.883

7.  Differential immune response modulation in early Leishmania amazonensis infection of BALB/c and C57BL/6 macrophages based on transcriptome profiles.

Authors:  Juliana Ide Aoki; Sandra Marcia Muxel; Ricardo Andrade Zampieri; Karl Erik Müller; Audun Helge Nerland; Lucile Maria Floeter-Winter
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.